{"slideshow_credits": null, "snippet": "Mr. Ackman of Pershing Square has stayed in the stock and sustained enormous losses on paper.", "abstract": "Pershing Square Capital Management has lost billions of dollars due to William A Ackman's bet on Valeant Pharmaceuticals International, which is putting pressure on Ackman and placing his reputation as bold moneymaker at risk.", "section_name": "Business Day", "print_page": "6", "document_type": "article", "byline": {"person": [{"firstname": "Alexandra", "role": "reported", "lastname": "STEVENSON", "rank": 1, "organization": ""}], "original": "By ALEXANDRA STEVENSON"}, "web_url": "http://www.nytimes.com/2016/03/16/business/dealbook/pressure-on-valeant-puts-william-ackmans-image-as-moneymaker-at-risk.html", "lead_paragraph": "Mr. Ackman of Pershing Square has stayed in the stock and sustained enormous losses on paper.", "headline": {"main": "Pressure on Valeant Puts William Ackman\u2019s Image as Moneymaker at Risk", "print_headline": "Huge Pressure on Valeant Puts Ackman\u2019s Image as a Moneymaker at Risk"}, "_id": "56e8a75b38f0d85c820e643d", "word_count": "943", "multimedia": [{"height": 126, "url": "images/2016/03/16/business/16Ackman/16Ackman-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/03/16/business/16Ackman/16Ackman-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 399, "url": "images/2016/03/16/business/16Ackman/16Ackman-articleLarge.jpg", "legacy": {"xlarge": "images/2016/03/16/business/16Ackman/16Ackman-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "399"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/03/16/business/16Ackman/16Ackman-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/16/business/16Ackman/16Ackman-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-03-16T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Pershing Square Capital Management", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "2"}, {"name": "persons", "value": "Ackman, William A", "is_major": "Y", "rank": "3"}, {"name": "subject", "value": "Hedge Funds", "is_major": "N", "rank": "4"}, {"name": "subject", "value": "Stocks and Bonds", "is_major": "N", "rank": "5"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N", "rank": "6"}], "blog": [], "subsection_name": "DealBook", "type_of_material": "News"}